-
1
-
-
0036291924
-
Are there time and cost savings by using telemanagement for patients on intensified insulin therapy?: A randomised, controlled trial
-
DOI 10.1016/S0169-2607(02)00037-8, PII S0169260702000378
-
Biermann E, Dietrich W, Rihl J, Standl E: Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Comput Methods Programs Biomed 2002;69:137-146. (Pubitemid 34722935)
-
(2002)
Computer Methods and Programs in Biomedicine
, vol.69
, Issue.2
, pp. 137-146
-
-
Biermann, E.1
Dietrich, W.2
Rihl, J.3
Standl, E.4
-
2
-
-
0036302980
-
Telemedicine as a tool for intensive management of diabetes: The DIABTel experience
-
DOI 10.1016/S0169-2607(02)00039-1, PII S0169260702000391
-
Gomez EJ, Hernando ME, Garcia A, Del Pozo F, Cermeno J, Corcoy R, Brugués E, De Leiva A: Telemedicine as a tool for intensive management of diabetes: the DIABTel experience. Comput Methods Programs Biomed 2002;69:163-177. (Pubitemid 34727368)
-
(2002)
Computer Methods and Programs in Biomedicine
, vol.69
, Issue.2
, pp. 163-177
-
-
Gomez, E.J.1
Hernando, M.E.2
Garcia, A.3
Del Pozo, F.4
Cermeno, J.5
Corcoy, R.6
Brugues, E.7
De Leiva, A.8
-
3
-
-
2342506512
-
Telecare for Patients with Type 1 Diabetes and Inadequate Glycemic Control: A randomized controlled trial and meta-analysis
-
DOI 10.2337/diacare.27.5.1088
-
Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC: Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27: 1088-1094. (Pubitemid 38579771)
-
(2004)
Diabetes Care
, vol.27
, Issue.5
, pp. 1088-1094
-
-
Montori, V.M.1
Helgemoe, P.K.2
Guyatt, G.H.3
Dean, D.S.4
Leung, T.W.5
Smith, S.A.6
Kudva, Y.C.7
-
4
-
-
34548423735
-
New technologies for chronic disease management and control: A systematic review
-
Garcia-Lizana F, Sarria-Santamera A: New technologies for chronic disease management and control: a systematic review. J Telemed Telecare 2007;13:62-68.
-
(2007)
J Telemed Telecare
, vol.13
, pp. 62-68
-
-
Garcia-Lizana, F.1
Sarria-Santamera, A.2
-
5
-
-
60449089649
-
Medical management of hyper-glycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyper-glycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32:193-203.
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Ferrannini, E.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
6
-
-
70350534273
-
Three-year efficacy of complex insulin regimensintype 2diabetes
-
Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK: Three-year efficacy of complex insulin regimensintype 2diabetes. NEngl JMed 2009;361:1736-1747.
-
(2009)
NEngl JMed
, vol.361
, pp. 1736-1747
-
-
Holman, R.R.1
Farmer, A.J.2
Davies, M.J.3
Levy, J.C.4
Darbyshire, J.L.5
Keenan, J.F.6
Paul, S.K.7
-
7
-
-
61549116581
-
Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study
-
Blickle JF, Hancu N, Piletic M, Profozic V, Shestakova M, Dain MP, Jacqueminet S, Grimaldi A: Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. Diabetes Obes Metab 2009;11:379-386.
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 379-386
-
-
Blickle, J.F.1
Hancu, N.2
Piletic, M.3
Profozic, V.4
Shestakova, M.5
Dain, M.P.6
Jacqueminet, S.7
Grimaldi, A.8
-
8
-
-
12844276465
-
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
-
DOI 10.2337/diacare.28.2.254
-
Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Jarvinen H: Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005;28: 254-259. (Pubitemid 40170922)
-
(2005)
Diabetes Care
, vol.28
, Issue.2
, pp. 254-259
-
-
Janka, H.U.1
Plewe, G.2
Riddle, M.C.3
Kliebe-Frisch, C.4
Schweitzer, M.A.5
Yki-Jarvinen, H.6
-
9
-
-
55449131463
-
Introducing a simplified approach to insulin therapy in type 2 diabetes: A comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
-
Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA: Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs. Diabetes Obes Metab 2008;10:1178-1185.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 1178-1185
-
-
Lankisch, M.R.1
Ferlinz, K.C.2
Leahy, J.L.3
Scherbaum, W.A.4
-
10
-
-
63449117033
-
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
-
Raccah D: Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus. Diabetes Obes Metab 2008;10(Suppl 2):76-82.
-
(2008)
Diabetes Obes Metab
, vol.10
, Issue.SUPPL. 2
, pp. 76-82
-
-
Raccah, D.1
-
11
-
-
34249807045
-
When basal insulin therapy in type 2 diabetes mellitus is not enough - What next?
-
DOI 10.1002/dmrr.733
-
Raccah D, Bretzel RG, Owens D, Riddle M: When basal insulin therapy in type 2 diabetes mellitus is not enough- what next? Diabetes Metab Res Rev 2007;23:257-264. (Pubitemid 46851465)
-
(2007)
Diabetes/Metabolism Research and Reviews
, vol.23
, Issue.4
, pp. 257-264
-
-
Raccah, D.1
Bretzel, R.G.2
Owens, D.3
Ridlle, M.4
-
12
-
-
80053385824
-
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: A 6-month 'proof-of-concept' study
-
Owens DR, Luzio SD, Sert-Langeron C, Riddle MC: Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. Diabetes Obes Metab 2011;13:1020-1027.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 1020-1027
-
-
Owens, D.R.1
Luzio, S.D.2
Sert-Langeron, C.3
Riddle, M.C.4
-
13
-
-
43049106459
-
Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes
-
Kim SI, Kim HS: Effectiveness of mobile and internet intervention in patients with obese type 2 diabetes. Int J Med Inform 2008;77:399-404.
-
(2008)
Int J Med Inform
, vol.77
, pp. 399-404
-
-
Kim, S.I.1
Kim, H.S.2
-
14
-
-
65649135889
-
Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: As effective as an Internet-based glucose monitoring system
-
Cho JH, Lee HC, Lim DJ, Kwon HS, Yoon KH: Mobile communication using a mobile phone with a glucometer for glucose control in Type 2 patients with diabetes: as effective as an Internet-based glucose monitoring system. J Telemed Telecare 2009;15:77-82.
-
(2009)
J Telemed Telecare
, vol.15
, pp. 77-82
-
-
Cho, J.H.1
Lee, H.C.2
Lim, D.J.3
Kwon, H.S.4
Yoon, K.H.5
-
15
-
-
70349516324
-
Telemedicine influence on the follow-up of type 2 diabetes patients
-
Rodriguez-Idigoras MI, Sepulveda-Munoz J, Sanchez-Garrido-Escudero R, Martinez-Gonzalez JL, Escolar-Castello JL, Paniagua-Gomez IM, Bernal-López R, Fuentes-Simón MV, Garófano-Serrano D: Telemedicine influence on the follow-up of type 2 diabetes patients. Diabetes Technol Ther 2009;11:431-437.
-
(2009)
Diabetes Technol Ther
, vol.11
, pp. 431-437
-
-
Rodriguez-Idigoras, M.I.1
Sepulveda-Munoz, J.2
Sanchez-Garrido-Escudero, R.3
Martinez-Gonzalez, J.L.4
Escolar-Castello, J.L.5
Paniagua-Gomez, I.M.6
Bernal-López, R.7
Fuentes-Simón, M.V.8
Garófano-Serrano, D.9
-
16
-
-
0242269000
-
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
DOI 10.2337/diacare.26.11.3080
-
Riddle MC, Rosenstock J, Gerich J: The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086. (Pubitemid 37339502)
-
(2003)
Diabetes Care
, vol.26
, Issue.11
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
17
-
-
84855858598
-
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR Study: Similar effects of telecare and conventional self monitoring of blood glucose on patient functional health status and treatment satisfaction
-
Nicolucci A, Del Prato S, Vespasianni G; ELEONOR Study Group: Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR Study: similar effects of telecare and conventional self monitoring of blood glucose on patient functional health status and treatment satisfaction. Diabetes Care 2011;34: 2524-2526.
-
(2011)
Diabetes Care
, vol.34
, pp. 2524-2526
-
-
Nicolucci, A.1
Del Prato, S.2
Vespasianni, G.3
-
18
-
-
49649123535
-
Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
-
Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M: Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008;31:1305-1310.
-
(2008)
Diabetes Care
, vol.31
, pp. 1305-1310
-
-
Bergenstal, R.M.1
Johnson, M.2
Powers, M.A.3
Wynne, A.4
Vlajnic, A.5
Hollander, P.6
Rendell, M.7
-
19
-
-
6944244979
-
Insulin detemir and insulin aspart: A promising basal-bolus regimen for type 2 diabetes
-
DOI 10.1016/j.diabres.2004.03.003, PII S0168822704000695
-
Raslova K, Bogoev M, Raz I, Leth G, Gall MA, Hancu N: Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004;66:193-201. (Pubitemid 39469347)
-
(2004)
Diabetes Research and Clinical Practice
, vol.66
, Issue.2
, pp. 193-201
-
-
Raslova, K.1
Bogoev, M.2
Raz, I.3
Leth, G.4
Gall, M.-A.5
Hancu, N.6
-
20
-
-
57649230070
-
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
-
Hollander P, Cooper J, Bregnhoj J, Pedersen CB: A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Clin Ther 2008;30: 1976-1987.
-
(2008)
Clin Ther
, vol.30
, pp. 1976-1987
-
-
Hollander, P.1
Cooper, J.2
Bregnhoj, J.3
Pedersen, C.B.4
-
21
-
-
70350605350
-
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
-
Raskin P, Gylvin T, Weng W, Chaykin L: Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes. Diabetes Metab Res Rev 2009; 25:542-548.
-
(2009)
Diabetes Metab Res Rev
, vol.25
, pp. 542-548
-
-
Raskin, P.1
Gylvin, T.2
Weng, W.3
Chaykin, L.4
-
22
-
-
78649713954
-
Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience
-
Foley JE, Jordan J: Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. Vasc Health Risk Manag 2010;6:541-548.
-
(2010)
Vasc Health Risk Manag
, vol.6
, pp. 541-548
-
-
Foley, J.E.1
Jordan, J.2
|